. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: Prostate. 2019 Jan 20;79(6):628–639. doi: 10.1002/pros.23767

TABLE 3.

In vivo CETSA data summary

	Treatment	T_m 50	ΔT_m50	R² value
DLAT	Solvent	48.69		0.9917
	Alteronol	45.61	−3.08	0.9865
DLST	Solvent	48.92		0.9963
	Alteronol	45.42	−3.58	0.9949
FH	Solvent	46.73		0.9923
	Alteronol	50.27	3.54	0.9866
MDH2	Solvent	44.96		0.9963
	Alteronol	45.12	0.16	0.9820